Testing an AI tool to screen for diabetic eye disease
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study uses an AI program called DRISTi to screen for diabetic eye disease by taking pictures of the back of your eye. It's designed for adults with diabetes who haven't had major eye treatments or vision loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older
- You have been diagnosed with diabetes
- You are willing to follow the study rules and be available for the whole study
- You do not have severe lasting vision loss in one or both eyes
- You have not had eye injections, laser treatment for the retina, or eye surgery (except routine cataract surgery)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated tool that checks for diabetic retinopathy, a common eye problem in people with diabetes. It may help catch the condition early, so vision loss can be prevented.
This trial tests an AI system that automatically checks eye photos for signs of diabetic retinopathy, a diabetes complication that can harm vision. If you have diabetes, this study may help detect the condition earlier and prevent vision loss.
This study looks at how images and other tests of the eye can help predict diabetic retinopathy, an eye problem caused by diabetes that can lead to vision loss. If you have diabetes, your eye health will be monitored closely. If you do not, you may participate as a healthy comparison.
This study uses an artificial intelligence (AI) tool to analyze eye images in people with type 2 diabetes. The goal is to see if the AI can help detect early signs of diabetic eye disease, so you can get the right care sooner.
This study tests whether a computer program (artificial intelligence) can use your eye scan images to help diagnose certain eye conditions. It might help catch problems earlier or more accurately, which could lead to better treatment.
This trial uses artificial intelligence to help diagnose eye conditions from digital eye images. If you have certain types of eye images from regular check-ups, your data might help teach the AI to recognise diseases better.
Hear when a new Diabetic Retinopathy (DR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.